Ignite Creation Date:
2025-12-25 @ 3:23 AM
Ignite Modification Date:
2025-12-26 @ 2:03 AM
Study NCT ID:
NCT05965505
Status:
TERMINATED
Last Update Posted:
2024-08-01
First Post:
2023-07-12
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Study of AXT-1003 in Adult Subjects With Relapsed/Refractory Non-Hodgkin Lymphomas
Sponsor:
Axter Therapeutics (Beijing) Co., Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-08-11
Start Date Type:
ACTUAL
Primary Completion Date:
2023-09-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-09-05
Completion Date Type:
ACTUAL
First Submit Date:
2023-07-12
First Submit QC Date:
None
Study First Post Date:
2023-07-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-31
Last Update Post Date:
2024-08-01
Last Update Post Date Type:
ACTUAL